-
VX-661 and the Next Logic of CFTR Rescue
2026-09-26
VX-661 can help researchers separate correction of F508del-CFTR trafficking from potentiation of channel activity. New evidence on calnexin-dependent CFTR expression adds a further experimental dimension: proteostasis context may influence variant response, but it should be tested rather than assumed.
-
Non-canonical ORFs Support Medulloblastoma Survival
2026-09-26
Hofman and colleagues combine ribosome profiling with CRISPR screens to show that non-canonical open reading frames are translated in medulloblastoma and can contribute to tumor-cell survival. Their work identifies the ASNSD1-uORF microprotein, ASDURF, as a survival-associated factor linked to the prefoldin-like complex, expanding the range of candidate mechanisms for follow-up in high-risk disease.
-
Concanavalin A Targets Conserved Coronavirus Glycans
2026-09-25
Guo and colleagues identify conserved, high-mannose N-linked glycans near the coronavirus spike S2′ cleavage site as a vulnerability that concanavalin A (ConA) can exploit to inhibit viral entry. Their fusion, pseudovirus, authentic-virus, biochemical, and animal experiments support a mechanism in which glycan binding obstructs spike activation, while leaving important questions about therapeutic safety and clinical relevance unresolved.
-
GW 6471 Workflows for PPARα Mechanism Studies
2026-09-25
Use GW 6471 to test whether PPARα activity contributes to exposure-linked liver and lipid phenotypes—not merely whether a pathway signature is present. This practical guide turns zebrafish PFHxS findings into controlled antagonist experiments, with dose planning, orthogonal validation, and troubleshooting for cellular metabolism and lipid homeostasis studies.
-
LY294002: PI3K Pathway Workflows and Applications
2026-09-24
Use LY294002 as a reversible PI3K pathway probe to connect early phospho-signaling changes with cell phenotypes in cancer and macrophage assays. A practical workflow pairs a dose-response pilot with viability controls and careful interpretation of its additional BET bromodomain activity.
-
IWP-2: A Wnt Production Inhibitor
2026-09-24
IWP-2 is a potent Wnt production inhibitor that targets Porcupine and can be used to investigate ligand-dependent Wnt signaling. Product information reports a 27 nM IC50 for Wnt pathway activity and describes antiproliferative effects in the gastric cancer cell line MKN28; these preclinical findings do not establish clinical efficacy.
-
Position-3 Design of GnRH Antagonists
2026-09-23
Samant and colleagues examined how replacing position 3 of degarelix with racemic 3-(2-methoxy-5-pyridyl)-alanine affected receptor antagonism and in vivo duration. The study links peptide stereochemistry to potency and pharmacological persistence, showing that the D-configured analogue retained strong in vitro activity whereas the L-configured analogue was substantially weaker and both compounds were short-acting in castrated male rats.
-
Indometacin Sodium in Remyelination Assays
2026-09-23
Indometacin Sodium Trihydrate supports both conventional inflammation assays and mechanistic remyelination workflows. Its COX-1/COX-2 activity can be paired with Wnt/β-catenin and GSK3β-oriented readouts to distinguish prostaglandin suppression from oligodendrocyte differentiation effects.
-
Optimized hiPSC Platelet Differentiation: Study Insights
2026-09-22
This 2026 study presents an optimized differentiation scheme that combines higher embryoid body input, human platelet lysate, and small-molecule control of megakaryocyte development. The protocol shortened production to 19 days, generated functional platelets at improved yield, and reduced reported costs, although further validation is needed for scale-up and clinical translation.
-
MK-0812 in MASH Monocyte Trafficking Workflows
2026-09-21
MK-0812 provides a receptor-proximal way to test whether CCR2-dependent monocyte trafficking contributes to gut–liver inflammation, complementing genetic and microbiota-based MASH models. Its human whole-blood potency and practical DMSO formulation support translational assay design from chemotaxis and flow cytometry to mouse studies.
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) Guide
2026-09-21
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables a cargo-first framework for studying cytokine expression, immune activation, and extrahepatic delivery. This article connects transcript chemistry with practical assay design and insights from an engineered virus-mimicking delivery study.
-
E-64 Workflows for Cysteine Protease Research
2026-09-20
E-64 provides irreversible, low-nanomolar control of cysteine proteases for active-site titration, lysosomal protease studies, and mechanistic cancer research. This guide connects purified-enzyme assays with lysosomal membrane permeabilization workflows while emphasizing controls for cell permeability, dosing, and assay interpretation.
-
Methylprednisolone: Mechanism and Bone Models
2026-09-19
Methylprednisolone is a synthetic glucocorticoid receptor agonist used in anti-inflammatory and translational research. Product data describe cytokine, chemokine, and NF-κB-related effects, while a rat study defines a glucocorticoid-induced osteonecrosis benchmark using 20 mg/kg methylprednisolone.
-
USP7–PKM2 Control of Macrophage Polarization in SAP
2026-09-19
A 2025 Cell Death & Disease study identifies USP7 as an upstream regulator of PKM2-dependent metabolic reprogramming in macrophages during severe acute pancreatitis. By combining genetic, metabolic, biochemical, and pharmacological experiments, the authors connect USP7-mediated PKM2 deubiquitination with M1 polarization and inflammatory disease severity.
-
MK-0812 in MASH Monocyte Trafficking Studies
2026-09-18
Use MK-0812 to separate CCR2-dependent monocyte recruitment from upstream gut–liver drivers in MASH experiments. Its nanomolar whole-blood activity supports translational chemotaxis, flow-cytometry, and in vivo workflow design with clear controls and troubleshooting checkpoints.